SEC Form 4 · accession 0001144204-15-027765
MusclePharm Corp · MSLP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John C Price
Officer — Chief Financial Officer
Period of report
Apr 28, 2015
Accepted (ET)
May 5, 2015 · 7:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001415684
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Restricted Common StockF1 | Apr 28, 2015 | J | 50,000 | — | A | 100,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Issued to Reporting Person from Issuer as compensation pursuant to the Reporting Person's employment agreement.